First of all, the tier of SRGE, the Expert Market. This is
First of all, the tier of SRGE, the Expert Market. This is NOT part of the Grey Market. How do I know this? Stocks trading on the Expert Market can get suspended. When they get suspended they drop down to Grey Market again. A Grey Market stock can get suspended but it will still stay on the Grey Market. For example ZOOM (now symbol ZTNO) got suspended on March 26th and got back to trading again on the Grey Market on April 9th. So, stocks on the Expert Market can get suspended and when they do, they drop down to Grey Market again.
The agreement GoGold has with the private owners of the mines, is worth around a total of $15 million. This isn't much and is somewhat comparable to what SRGE had in the beginning. They got the concession titles for these mines and as exploration company the mines were optioned also around these prices, albeit a little lower. GoGold still is exploring these mines and drilling.
They won't be making any real money out of this unless they sell these mines to a senior gold producer. Just as SRGE wanted to sell the mines to Kinross, GoGold eventually will try and do the same. Or, a senior gold producer will come knocking on GoGold's door after GoGold is done exploring and offer GoGold a huge amount of money for the mines.
On the other side, we have Ihub bashers who kept insisting SRGE was a scam and didn't have any mines. These same mines are now in the hands of GoGold Resources. Why isn't anyone from the Ihub basher team complaining to GoGold Resources that these private owners of these mines are scamming them? GoGold was at 20 cents and on the regular Grey Market before they got these mines. Now they're at 52 cents and on the OTCQX International tier. And this is all because of the Los Ricos/Cinco Minas mines which were SRGE's before. Ihub bashers robbed SRGE shareholders of money and they know it.
Even with all of this going on, the SRGE shares are still being bought, even after 7 years! The million dollar question remains: who is buying these SRGE shares and why?
1
Southridge Enterprises Inc. (SRGE) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Real Customer Signal, Minus the Revenue Figure An updated image is the least interesting detail in this release. Sidus Space has landed a purchase order from Argotec Group to manufacture cable assemblies for the HAWK satellite platform, with delivery expected in the first quarter of 2027. That is a legitimate operational win for NASDAQ:SIDU. It brings in a new...
Continue Reading
Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...
Continue Reading
Governance Has Finally Reached the Engine Room Enterprise AI is no longer a shiny pilot parked in some innovation lab; it is creeping into business-critical work, and that changes the argument entirely. Frost & Sullivan’s latest analysis makes a sensible point that too many executives still resist: AI governance is becoming a strategic operating capability, not merely a...
Continue Reading
A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...
Continue Reading
A medication change scribbled on a loose sheet can become a very long night. That is the unglamorous truth behind the discussion from Michael and Marsha Reda of Aurora Home Care in Williamsville, New York: long-term home nursing care depends on a plan people can actually follow when the household is tired, worried, and juggling too much. Their perspective, featured by...
Continue Reading
Six straight appearances on Deloitte's Fast 500 is not random confetti; it says Branch has kept finding customers while plenty of fintech outfits were busy shrinking their ambitions. The Tampa-based workforce-payments company landed at No. 146 in the 2026 ranking, which measures fiscal-year revenue growth from 2022 through 2025. That is a respectable showing in a list...
Continue Reading
August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...
Continue Reading
Suspicion may rattle a courtroom, but it apparently does not always loosen the jury’s purse strings. That is the useful, slightly sobering takeaway from DOAR’s new national study on damages in trade secret disputes, released November 20, 2026. Jurors, according to the report, draw a meaningful line between an employee carrying experience to a new job and a company...
Continue Reading
A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...
Continue Reading
A frozen turkey is not a grand strategy deck, thank goodness; it is dinner for a household that might be feeling the squeeze. Story Cannabis plans to hand out 840 of them on Tuesday, Nov. 24, splitting the giveaway between Columbus and Cleveland with former Ohio State and Dallas Cowboys running back Michael Wiley joining employees and volunteers. In a cannabis business...
Continue Reading
Top 5 Most Recently Viewed Articles
PAPZIMEOS: A Promising New Standard for RRP Therapy PAPZIMEOS (zopapogene imadenovec) has gained recognition as an innovative treatment for adults suffering from recurrent respiratory papillomatosis (RRP). This breakthrough comes following the publication of a consensus paper authored by 16 leading experts in the field. Sponsored by the Recurrent Respiratory...
Continue Reading
Ollie's Bargain Outlet Achieves Strong Q2 Performance Ollie's Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) has made headlines recently as its shares experience fluctuations in the market. The company revealed impressive second-quarter adjusted earnings per share of 99 cents, surpassing analyst expectations of 94 cents. The quarterly sales reached $679.556 million, marking...
Continue Reading
Fivecast Unveils Discovery Solution to Combat Global Threats In today's rapidly evolving landscape of global threats, Fivecast, a prominent provider of advanced open-source intelligence (OSINT) solutions, has rolled out an innovative Discovery solution designed to assist analysts and investigators in both government and corporate settings. By elevating the speed and...
Continue Reading
Zen Technologies USA Showcases Cutting-Edge AI Simulations Zen Technologies USA is set to revolutionize military training capabilities with its next-generation AI-enabled live and virtual simulation solutions. By enabling high-fidelity training for ground and naval forces, these innovations aim to accelerate the readiness of military units while significantly reducing...
Continue Reading
Revolutionizing Radiology with Innovative Integrations International medical imaging IT and cybersecurity company Sectra (STO: SECT B) and Siemens Healthineers AG have formed a pivotal collaboration aimed at enhancing diagnostic capabilities in the radiology field. This initiative seeks to improve patient care by enabling seamless access to advanced imaging technologies....
Continue Reading